Warning letter
Serpe & Sons Inc: warning letter of Apr 4, 2014
FDA warning letter 423653 · Philadelphia District Office
Key facts
| Reference number | 423653 |
|---|---|
| Company | Serpe & Sons Inc |
| Subject | CGMP Food/Prepared, Packed or Held Under Insanitary Conditions/Adulterated |
| Issue date | Apr 4, 2014 |
| Posted date | Apr 15, 2014 |
| Issuing office | Philadelphia District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 110, 110.93, 110.10(b)(1), 110.10(b)(7), 110.20(b)(1), 110.20(b)(4), 110.35(a), 110.35(b)(2), 110.37(b)(4), 110.37(e)(2), 110.37(e)(5), 110.80(a)(1) and 1 more |
| Inspection city | Elsmere |
| Inspection ZIP | 19805 |
| Inspection start date | Feb 27, 2014 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: